Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure

Autores organización
Autores
- Rios R
- Dinh A
- Kolokotronis S.-O.
- Narechania A
- Tran TT
- Munita JM
- Murray BE
- Planet PJ
- Arias CA
- Diaz L
Grupos de investigación
Resumen
Little is known about the population structure of vancomycin-resistant Enterococcus faecium (VREfm) in Latin America (LATAM). Here, we provide a complete genomic characterization of 55 representative Latin American VREfm recovered from 1998–2015 in 5 countries. The LATAM VREfm population is structured into two main clinical clades without geographical clustering. Using the LATAM genomes, we reconstructed the global population of VREfm by including 285 genomes from 36 countries spanning from 1946 to 2017. In contrast to previous studies, our results show an early branching of animal related isolates and a further split of clinical isolates into two sub-clades within clade A. The overall phylogenomic structure of clade A was highly dependent on recombination (54% of the genome) and the split between clades A and B was estimated to have occurred more than 2,765 years ago. Furthermore, our molecular clock calculations suggest the branching of animal isolates and clinical clades occurred ~502 years ago whereas the split within the clinical clade occurred ~302 years ago (previous studies showed a more recent split between clinical an animal branches around ~74 years ago). By including isolates from Latin America, we present novel insights into the population structure of VREfm and revisit the evolution of these pathogens. © 2020, The Author(s).
Datos de la publicación
- ISSN/ISSNe:
- 2045-2322, 2045-2322
- Tipo:
- Article
- Páginas:
- 5636-5636
- Enlace a otro recurso:
- www.scopus.com
Scientific Reports Nature Research
Citas Recibidas en Web of Science: 34
Citas Recibidas en Scopus: 45
Documentos
- No hay documentos
Filiaciones
Keywords
- Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genomics; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci; antiinfective agent; vancomycin; article; calculation; cladistics; infectious agent; molecular clock; nonhuman; population structure; South and Central America; vancomycin resistant Enterococcus; cross infection; drug effect; Enterococcus faecium; epidemic; genetics; genomics; genotype; Gram positive infection; human; microbial sensitivity test; microbiology; molecular epidemiology; phylogeny; procedures; vancomycin resistant Enterococcus
Proyectos asociados
Consorcio de resistencia a carbapenems en Klebsiella pneumoniae y otras enterobacteriaceae (CRACKLE): un estudio de cohorte prospectivo y observacional” en su componente de coordinación clínica. En inglés. Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae (CRACKLE): a Prospective, Observational Cohort Study (CRACKLE II). Componente clínico. Ultimo año. Nuevo título. Red de organismos multiresistentes MDRO “ARLG MDRO SOUTH &CENTRAL AMERICA”
Investigador Principal: JINNETHE CRISTINA REYES MANRIQUE
UEB-2017-456 . 2017
Caracterización del efecto inóculo a cefazolina en Staphylococcus aureus susceptibles a Meticilina (MSSA) causantes de infecciones: implementación de una prueba de detección rápida - Rapid IE - MSSA
Investigador Principal: SANDRA LILIANA RINCON NUÑEZ
UEB-2018-475 . 2018
Dinámicas de colonización e infección por microorganismos multidrogorresistentes en pacientes de hospitales de alta complejidad
Investigador Principal: JINNETHE CRISTINA REYES MANRIQUE
UEB-2018-476 . 2018
Citar la publicación
Rios R,Reyes J,Carvajal LP,Rincon S,Panesso D,Echeverri AM,Dinh A,Kolokotronis S-O,Narechania A,Tran TT,Munita JM,Murray BE,Planet PJ,Arias CA,Diaz L. Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure. Sci Rep. 2020. 10. (1):p. 5636-5636. IF:4,379. (1).